Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: March 2007
-
By Christopher P. Singer — Ocean Tomo® will hold its first live intellectual property auction of 2007 in Chicago on April 18-19. It’s first two auction events, held in April and October 2006, resulted in $8.5 million and $23 million of transactions, respectively. The auction is held much the same as a traditional…
-
By Donald Zuhn — In an appeal from a District Court judgment of validity, enforceability, and infringement, the Federal Circuit reversed the District Court’s finding of validity, holding that U.S. Patent No. 4,879,303 (the ‘303 patent) was rendered obvious by, inter alia, U.S. Patent No. 4,572,909 (the ‘909 patent) and Berge, 1977, "Pharmaceutical…
-
March 25-29, 2007 – American Chemical Society National Meeting – Chicago, IL April 13, 2007 – "Of Brics & Mortar: Technological Drivers in Booming Economies" Symposium (Northwestern Journal of Technology and Intellectual Property) – Chicago, IL April 16-18, 2007 – Biotechnology: Patent Prosecution, Licensing, Litigation & Hatch-Waxman (Patent Resources Group) – Orlando, FL April 27,…
-
By Kevin E. Noonan — Since the Federal Circuit’s en banc decision in Cybor Corp. v. FAS Technologies, Inc. that no aspect of a district court’s claim construction was entitled to any deference, courts, commentators, and other critics have disagreed with the Federal Circuit. Today, Amgen has enlisted the aid of the Supreme…
-
By Bradley Crawford — In 1998, the Administrative Council of the European Patent Organisation, seeking to update the European Patent Convention (EPC), agreed on a catalog of potential revisions (see "EPC 2000"). A Task Force was then formed to prepare detailed proposals for revision of the EPC, which were examined and refined in…
-
By Kevin E. Noonan — Somewhere between Darwin’s On the Origin of Species and Watson and Crick’s discovery of the double helix, biology changed from its roots as "natural history" into a modern science. Biology (and biologists) retain some residual fondness for the "butterfly collecting" aspects of the profession, however; something illustrated by…
-
By Kevin E. Noonan — Before starting the Iraq war, the Bush Administration action with the most long-lasting effect and significance was its decision, in August 2001, to restrict Federal funding of human embryonic stem cell research. The government refused to fund research on any stem cell line not existing at the time…
-
The second annual symposium of the Northwestern Journal of Technology and Intellectual Property will be held at the Northwestern University School of Law on April 13, 2007. The symposium, entitled "Of Brics & Mortar: Technological Drivers in Booming Economies" will provide a discussion on a number of topics that may determine whether developing economies (the…
-
By Donald Zuhn — Last Friday, NimbleGen Systems, Inc. announced that it had filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. According to NimbleGen’s press release, neither the number of shares nor the offering price had yet been determined. MarketWatch and…
-
Windhover Information Inc. will be holding the 14th Annual Euro-Biotech Forum 2007 on June 26-28, 2007 in Paris, France. According to Windhover, Euro-Biotech offers European and American life sciences companies an opportunity to network with hundreds of potential pharmaceutical and biotech partners, with one to one meetings between Forum participants being scheduled using Windhover's partnering…
Patent Docs 